Patent details

EP2542220 Title: USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE

Basic Information

Publication number:
EP2542220
PCT Application Number:
PCT/FI/2011/000013
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117094466
PCT Publication Number:
WO/2011/107653
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE
French Title of Invention:
MÉTHODE DE TRAITEMENT DE LA MALADIE DE PARKINSON
German Title of Invention:
VERWENDUNG VON LEVODOPA, CARBIDOPA UND ENTACAPON ZUR BEHANDLUNG VON MORBUS PARKINSON
SPC Number:

Dates

Filing date:
03/03/2011
Grant date:
02/11/2016
EP Publication Date:
02/11/2016
PCT Publication Date:
09/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/01/2013
EP B1 Publication Date:
02/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/03/2017
Expiration date:
03/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/03/2011
 
 

Name:
Orion Corporation
Address:
Orionintie 1, 02200 Espoo, Finland (FI)

Inventor

1

Name:
ROURU Juha
Address:
Finland (FI)

2

Name:
MÄNNISTÖ Pekka
Address:
Finland (FI)

3

Name:
ELLMEN Juha
Address:
Finland (FI)

4

Name:
KUOPPAMÄKI Mikko
Address:
Finland (FI)

Priority

1

Priority Number:
310398 P
Priority Date:
04/03/2010
Priority Country:
United States (US)

2

Priority Number:
412821 P
Priority Date:
12/11/2010
Priority Country:
United States (US)

3

Priority Number:
438416 P
Priority Date:
01/02/2011
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/277;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages